ELONVA Practice Integration Meeting, Lübeck, 11/2011

The final clinical observation programme of 2011 — aimed at integrating the new long-acting gonadotropin (ELONVA) into ovarian stimulation for IVF in clinical practice. Reproductive medicine specialists from Europe and the United States took part.

Invited lectures:

Agonists vs antagonists

The history of ovarian stimulation using GnRH analogues.

Optimal Usage of the Antagonist Protocol in IVF with case studies

Lessons from a decade of GnRH antagonist use in ovarian stimulation.